Table 2.
Characteristics of patients with and without SC at 24hrs after AIS.
| Variable | SC (n=37) | No SC (n=54) | OR (95% Cl) |
|---|---|---|---|
| Age [mean (sd)] | 73 ± 14.3 | 67 ±14.0 | 1.03 (1.0–1.1, p=0 04)** |
| Age >75 | 51.3% (19) | 27.3% (15) | 2.74 (1.1–6.6, p=0.02)** |
| Female | 48.6% (18) | 42.6% | 0.78 (0.34–1.82, p=0.60) |
| African American race | 35.1% (13) | 20.4% (11) | 2.68 (1.0–7.0, p = 0.04)** |
| BMI >30 | 35.1% (13) | 25.9% (14) | 1.35 (0.62–3.84, p=0.30) |
| Hypertension | 81.1% (30) | 79.6% (43) | 1.1 (0.31–3.15, p=0.90) |
| Hyperlipidemia | 32.4% (12) | 33.3% (10) | 0.96 (0.39–2.34, p=0.93) |
| Diabetes Mellitus | 32.4% (12) | 27.8% (15) | 1.25 (0.5–3.1, p=0.63) |
| Coronary Artery Disease | 16.2% (6) | 16.7% (9) | 0.97 (0.31–3.0, p=0.95) |
| Prior Stroke | 48.6% (18) | 33.3% (13) | 1.89 (0.80–4.47, p=0.14) |
| Smoking | 16.2% (6) | 31.5% (17) | 0.53 (0.22–2.34, p=0.93) |
| Hgb A1C | 6.22 ±16 | 6.45 ±1.8 | 0.90 (0.68–1.20, p=0.35) |
| LDL | 91.1 ±39 | 98.8 ±33 | 0.99 (0.98–1.00, p=0.35) |
| Length of stay | 6.1 ±5.0 | 5.5 ±4.0 | 1.03 (0.94–1.13, p = 0.5) |
| Admission BB use | 54.1% (20) | 27.3% (15) | 3.06 (1.27–7.37, p=0.01)** |
| Admission NIHSS [median (IQR)] | 8 (6–16) | 7.5 (4–13) | 1.0 (0.96–1.06, p=0.70) |
| Intubation during hospitalization | 10.8% (4) | 14.8% (8) | 0.58 (0.19–2.5, p=0.70) |
| Discharge mRS 0–3 | 62.1% (23) | 70.4% (33) | 1.61 (0.65–4.0, p=0.30) |
| tPA | 67.6% (25) | 59.3% (32) | 1.43 (0.60–3.44, p=0.40) |
| Insular cortex involvement | 37.8% (14) | 40.7% (22) | 0.39 (0.38–2.09, p=0.80) |
| Hemorrhagic transformation | 21.6% (8) | 20.4% (11) | 1.08 (0.39–3.00, p=0.90) |
| Stroke side Left | 40.5% (15) | 35.2% (19) | |
| Right | 29.7% (11) | 44.4% (24) | 0.71 (0.69–1.2, p = 0.20) |
| Multiple | 5.4% (2) | 3.7% (2) | |
| Posterior circulation stroke | 24.3% (9) | 13.0% (54) | 2.16 (0.72–6.44, p=0.20) |
| Infarct volume | 19.6 ±52 | 33.1 ±60 | 1.00 (0.99–1.00, p=0.29) |
| Infection during admission | 21.6% (8) | 13.5% (10) | 1.38 (0.40–4.98, p=0.60) |
| Etiology LVA | 13.5% | 11.1% | |
| CE | 48.6% | 48.1% | |
| SVA | 5.4% | 14.8% | 1.11 (0.75–1.63, p=0.6) |
| Cryptogenic | 24.3% | 241% | |
| Other | 0 | 5.56% |
BMI=body mass index; BB=beta blocker; mRS=modified Rankin score; tPA=tissue plasminogen activator; LVA=large vessel atherosclerosis; CE=cardioembolic; SVA=small vessel arteriopathy; CI=confidence interval
**
p < 0.05